Literature DB >> 20016240

Preoperative detection of cervical lymph node metastases in papillary thyroid cancer: a surgical perspective.

George H Sakorafas1, Spiros Christodoulou, Christos Lappas, Michael Safioleas.   

Abstract

Despite its relatively benign biological behavior, papillary thyroid cancer is frequently associated with cervical lymph node metastases at the time of diagnosis. These metastases have a limited impact on overall survival, but are recognized as a significant risk factor for locoregional recurrence of the disease. This may significantly alter quality of life, and may require further therapeutic interventions which may be associated with increased morbidity. Therefore, preoperative identification of cervical lymph node metastases is of particular importance and allows optimal and effective treatment at the time of initial surgery. Clinical examination remains important but lacks sensitivity. Neck ultrasonography is currently the most useful method to detect cervical lymphadenopathy. Fine-needle aspiration (for cytology and thyroglobulin measurement), usually under ultrasonographic guidance, may confirm the diagnosis of lymph node metastases. Other imaging methods (including computed tomography, magnetic resonance imaging, positron emission tomography) should be used selectively. A compartment-oriented cervical lymph node dissection should be performed at the time of thyroidectomy if preoperative evaluation reveals cervical lymphadenopathy. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20016240     DOI: 10.1159/000255337

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  2 in total

1.  The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer.

Authors:  Davit Kocharyan; Frank Schwenter; Manon Bélair; Edgard Nassif
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

2.  Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma.

Authors:  Suvi Renkonen; Riikka Lindén; Leif Bäck; Robert Silén; Hanna Mäenpää; Laura Tapiovaara; Katri Aro
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-02       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.